Relx Plc (NYSE:RELX) Shares Bought by Baker Chad R

Baker Chad R raised its position in Relx Plc (NYSE:RELX - Free Report) by 50.3% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 169,025 shares of the technology company's stock after purchasing an additional 56,575 shares during the period. Relx accounts for approximately 1.7% of Baker Chad R's portfolio, making the stock its 26th biggest holding. Baker Chad R's holdings in Relx were worth $8,521,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in RELX. Bank of America Corp DE lifted its position in Relx by 4.2% during the fourth quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock worth $283,714,000 after buying an additional 253,107 shares in the last quarter. Lazard Asset Management LLC grew its holdings in Relx by 1.2% in the 4th quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company's stock valued at $191,868,000 after buying an additional 48,793 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Relx by 4.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,189,886 shares of the technology company's stock worth $144,885,000 after acquiring an additional 121,831 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Relx by 368.7% during the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock worth $127,437,000 after acquiring an additional 2,208,119 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Relx by 51.6% during the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after acquiring an additional 745,532 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on RELX. Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Morgan Stanley restated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Finally, The Goldman Sachs Group assumed coverage on shares of Relx in a research note on Wednesday, March 26th. They set a "buy" rating for the company. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Relx currently has an average rating of "Buy".

Relx Stock Performance

Shares of Relx stock traded down $0.53 on Friday, hitting $52.73. The stock had a trading volume of 532,504 shares, compared to its average volume of 727,510. The stock has a market cap of $97.34 billion, a price-to-earnings ratio of 28.35, a P/E/G ratio of 2.73 and a beta of 0.84. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. Relx Plc has a 52-week low of $43.45 and a 52-week high of $56.33. The company's 50 day moving average price is $52.99 and its 200 day moving average price is $49.91.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.